newsfilter
← Latest News
GlobeNewswire·

Aclaris Therapeutics Announces Leadership Transition

- Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as Part of Planned